Nam Tran
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nam Tran has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Elina Quiroga
Division of Vascular Surgery, Department of Surgery, University of Washington, Seattle, WA
3 shared publications Niten Singh
University of Washington, Seattle, WA
3 shared publicationsBenjamin Starnes
University of Washington, Seattle, WA
2 shared publicationsAmir Ghaffarian
University of Washington, Seattle, WA
1 shared publicationBenjamin W. Starnes
Division of Vascular Surgery, Department of Surgery, University of Washington, Seattle, WA
1 shared publicationDevang Padalia
1 shared publication
Latest Publications
- 3 February 2022
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 79, 393-394
Clinical Outcomes Of A Diagnostic And Management Protocol For Popliteal Artery Entrapment Syndrome At A Large Referral Center
- 3 February 2022
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 79, 393-394
Clinical Outcomes Of A Diagnostic And Management Protocol For Popliteal Artery Entrapment Syndrome At A Large Referral Center
- 1 May 2021
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 73, 22-26
Reevaluating the Need for Routine Coverage of the Left Subclavian Artery in Thoracic Blunt Aortic Injury
- 1 May 2021
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 73, 22-26
Reevaluating the Need for Routine Coverage of the Left Subclavian Artery in Thoracic Blunt Aortic Injury
- 1 May 2021
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 73, 15-21
Management of Moderate Blunt Thoracic Aortic Injuries in Patients with Intracranial Hemorrhage
- 1 May 2021
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 73, 15-21
Management of Moderate Blunt Thoracic Aortic Injuries in Patients with Intracranial Hemorrhage
- 3 April 2017
- Published by Taylor & Francis in Journal of Pain & Palliative Care Pharmacotherapy
- Vol. 31 (2) , 139-143
Intrathecal Injection of Gadobutrol: A Tale of Caution
In the field of interventional pain medicine a radiocontrast agent is commonly used in conjunction with fluoroscopy. Limited work has been published regarding the use of gadolium based contrast agents (GBCA) in the intrathecal space. We report a case of an intrathecal gadobutrol injection resulting in neurotoxic manifestations.A 60-year-old female with a history significant for lumbar post-laminectomy syndrome and intrathecal drug delivery implantation was admitted for lumbar fusion and kyphoplasty. Postoperatively, the patient had escalating pain medication requirements. A pump and intrathecal catheter contrast study was completed to assess the integrity and proper placement of the intrathecal catheter. Due to patient.s allergy to iodinated contrast, the physician requested gadolinium contrast dye. Unknown to the staff was that Magnevist had recently been replaced with an alternative GBCA, Gadavist (gadobutrol). 2 cc of Gadavist was injected. The catheter was determined to be intact and in proper position. Less than five minutes after the injection of gadobutrol, the patient reported spastic pain of the lower extremities. There is a lack of evidence as it relates to the use of GBCA specifically gadobutrol in the intrathecal space. The use of gadobutrol in the intrathecal space should be used with caution.
- 3 April 2017
- Published by Taylor & Francis in Journal of Pain & Palliative Care Pharmacotherapy
- Vol. 31 (2) , 139-143
Intrathecal Injection of Gadobutrol: A Tale of Caution
In the field of interventional pain medicine a radiocontrast agent is commonly used in conjunction with fluoroscopy. Limited work has been published regarding the use of gadolium based contrast agents (GBCA) in the intrathecal space. We report a case of an intrathecal gadobutrol injection resulting in neurotoxic manifestations.A 60-year-old female with a history significant for lumbar post-laminectomy syndrome and intrathecal drug delivery implantation was admitted for lumbar fusion and kyphoplasty. Postoperatively, the patient had escalating pain medication requirements. A pump and intrathecal catheter contrast study was completed to assess the integrity and proper placement of the intrathecal catheter. Due to patient.s allergy to iodinated contrast, the physician requested gadolinium contrast dye. Unknown to the staff was that Magnevist had recently been replaced with an alternative GBCA, Gadavist (gadobutrol). 2 cc of Gadavist was injected. The catheter was determined to be intact and in proper position. Less than five minutes after the injection of gadobutrol, the patient reported spastic pain of the lower extremities. There is a lack of evidence as it relates to the use of GBCA specifically gadobutrol in the intrathecal space. The use of gadobutrol in the intrathecal space should be used with caution.
- 13 January 2017
- Published by Springer Nature
- p. 7-13
Background Scope of the Problem